Jim Cramer gets quizzed about stocks from viewers of his Mad Money program during the Lightning Round segment. I get emails sometimes from readers of Real Money. One money manager in a suburb of humid Houston, Texas, asked me about AbbVie (ABBV) . Let's check and see what the charts of this biopharma company are up to.
More from Investing
Uber's ride-sharing business continues seeing demand gradually improve from its March/April lows. But it's still far below pre-COVID levels.
The indexes ramped higher yet again and were primarily driven by Apple and Facebook.
Covid-19 has not eliminated the power of compounding, it has just made certain people forget about it.